Adaptimmune to Participate in Two Bank Conferences this September

Company Participation in Conferences - Adaptimmune Therapeutics plc will participate in two investment bank conferences in September 2024, including the Wells Fargo Healthcare Conference on September 4 and the H.C. Wainwright 26th Annual Global Investment Conference on September 9 [2] - Both events will feature fireside chats and will be webcast live, with replays available for a limited time after the presentations [2] Company Overview - Adaptimmune is a fully integrated cell therapy company focused on redefining cancer treatment through its engineered T cell receptor (TCR) platform [3] - The company aims to develop personalized medicines that target and destroy difficult-to-treat solid tumor cancers, enhancing the overall cancer treatment experience for patients [3]